Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy

Clinical trial NCT05410938 · COMPLETED

Trial details

NCT number: NCT05410938
Sponsor: Far Eastern Memorial Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Intraperitoneal Chemotherapy, Bevacizumab, Ovarian Cancer

Start date: 2022-06-06
Primary completion: 2023-05-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.